11.99
1.88%
-0.23
After Hours:
11.12
-0.87
-7.26%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Lifevantage Corporation stock is traded at $11.99, with a volume of 102.57K.
It is down -1.88% in the last 24 hours and up +11.22% over the past month.
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.
See More
Previous Close:
$12.22
Open:
$12.22
24h Volume:
102.57K
Relative Volume:
1.12
Market Cap:
$151.43M
Revenue:
$212.99M
Net Income/Loss:
$2.56M
P/E Ratio:
59.95
EPS:
0.2
Net Cash Flow:
$9.47M
1W Performance:
-2.52%
1M Performance:
+11.22%
6M Performance:
+78.96%
1Y Performance:
+68.87%
Lifevantage Corporation Stock (LFVN) Company Profile
Name
Lifevantage Corporation
Sector
Industry
Phone
801-432-9000
Address
3300 TRIUMPH BLVD, LEHI
Lifevantage Corporation Stock (LFVN) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Sep-08-14 | Initiated | Midtown Partners | Buy |
Feb-12-14 | Initiated | Imperial Capital | In-line |
Lifevantage Corporation Stock (LFVN) Latest News
LifeVantage to Announce First Quarter Fiscal Year 2025 Results on October 29, 2024 - ForexTV.com
LifeVantage (NASDAQ:LFVN) Stock Crosses Above 200 Day Moving AverageShould You Sell? - MarketBeat
(LFVN) Proactive Strategies - Stock Traders Daily
LifeVantage Launches GLP-1 System - Direct Selling News
LifeVantage announces U.S. launch of MindBody GLP-1 System - TipRanks
LifeVantage Introduces the MindBody GLP-1 System™ Transforming Weight Management into a Sustainable Lifestyle - GlobeNewswire
LifeVantage (NASDAQ:LFVN) Shares Cross Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
How to Take Advantage of moves in (LFVN) - Stock Traders Daily
LifeVantage Updates Evolve Compensation Plan - Direct Selling News
LifeVantage Announces Update to Evolve Compensation Plan with New Sharing Bonus - GlobeNewswire
Subdued Growth No Barrier To LifeVantage Corporation (NASDAQ:LFVN) With Shares Advancing 63% - Simply Wall St
LifeVantage GLP-1: Hoping To Change Things Up In The Weight-Management Space (NASDAQ:LFVN) - Seeking Alpha
LifeVantage Co. (NASDAQ:LFVN) Sees Significant Growth in Short Interest - MarketBeat
LifeVantage concludes GLP-1 weight management trial - Investing.com India
LifeVantage completes human clinical trial with new GLP-1 system - TipRanks
LifeVantage Completes Successful Human Clinical Trial with New GLP-1 System for Activated Weight Loss* † - The Manila Times
LifeVantage Corporation's (NASDAQ:LFVN) market cap rose US$21m last week; retail investors who hold 51% profited and so did insiders - Simply Wall St
LifeVantage concludes GLP-1 weight management trial By Investing.com - Investing.com UK
LifeVantage stock soars to 52-week high, hits $10.97 By Investing.com - Investing.com Australia
LifeVantage stock soars to 52-week high, hits $10.97 - Investing.com
Investors in LifeVantage (NASDAQ:LFVN) have seen notable returns of 69% over the past year - Yahoo Finance
(LFVN) Trading Advice - Stock Traders Daily
LifeVantage stock soars to 52-week high, hits $10.48 By Investing.com - Investing.com Australia
LifeVantage stock soars to 52-week high, hits $10.48 - Investing.com India
Where are the Opportunities in (LFVN) - Stock Traders Daily
LifeVantage Study Shows Positive Results for New GLP-1 System - Direct Selling News
LFVNLifevantage Corporation Latest Stock News & Market Updates - StockTitan
LifeVantage proxy fight heats up as revenues cool - Natural Products Insider
LifeVantage Announces Positive In Vitro Results for New - GlobeNewswire
LifeVantage reports GLP-1 production boost in study - Investing.com
LifeVantage Announces Positive In Vitro Results for New GLP-1 System Showing Synergistic Gene Activation for Enhanced Weight Management* † - StockTitan
LIFEVANTAGE CORPORATION - Marketscreener.com
LifeVantage stock soars to 52-week high, hits $9.17 By Investing.com - Investing.com Canada
LifeVantage stock soars to 52-week high, hits $9.17 - Investing.com
LifeVantage Jumps on Bringing Lemonade Permanently - MSN
Here's Why We're Wary Of Buying LifeVantage's (NASDAQ:LFVN) For Its Upcoming Dividend - Simply Wall St
Lifevantage director Garry Paul Mauro buys $11,848 in company stock - Investing.com
Lifevantage director Garry Paul Mauro buys $11,848 in company stock By Investing.com - Investing.com UK
We Think LifeVantage's (NASDAQ:LFVN) Solid Earnings Are Understated - Simply Wall St
LifeVantage to Participate in the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewswire
LifeVantage Welcomes Back AXIO® Lemonade—Now As a Permanent Flavor - GlobeNewswire
Lifevantage Corporation [LFVN] Investment Guide: What You Need to Know - Knox Daily
Investors in cash trouble should check out Lifevantage Corporation (LFVN) - SETE News
Lifevantage Corporation (LFVN)’s stock rises to 7.96 per share - US Post News
LifeVantage (NASDAQ:LFVN) Releases Quarterly Earnings Results, Misses Estimates By $0.07 EPS - MarketBeat
LifeVantage Co. (NASDAQ:LFVN) Plans $0.04 Quarterly Dividend - MarketBeat
Q4 2024 LifeVantage Corp Earnings Call - Yahoo Finance UK
Lifevantage Shares Fall on Lower 4Q Earnings - MarketWatch
LifeVantage Corporation (NASDAQ:LFVN) Q4 2024 Earnings Call Transcript - Insider Monkey
Lifevantage Corporation Stock (LFVN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):